B+
Bull case
25%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-10-14 · RankAlpha Sentiment Codex
ADAG
AdageneDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The reported $127.9 million June 2026 cash balance and company-expected runway into late 2028 provide time for the Phase 2 readout. Earlier muzastotug cohorts and additional pipeline activity offer upside if subsequent controlled data support efficacy and a tolerable regimen [#PR-EARNINGS-2026-08-12] [#PR-2026-09-22].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
ADG138 has IND clearance but no human safety or efficacy results in the checked company announcement [#PR-2026-09-22].
Momentum
87
Value
41
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.30 · Bull $4.50 · Bear $0.90Analysis 2026-10-14; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-28 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-14 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-28
Investment thesis
As of 2026-10-28
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $9.74
Why
Momentum87 · Δ7d -
Value41 · Δ7d -0.1
Sentiment51 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • ADG138 has IND clearance but no human safety or efficacy results in the checked company announcement [#PR-2026-09-22].
- • Randomized Phase 2 efficacy may not reproduce the earlier nonrandomized cohort signals [#PR-EARNINGS-2026-08-12].
- • The value-defining randomized result remains pending.
Catalyst clock
2026-12-31
ADG138 first-in-human study initiation
Lead driver: Sentiment · See AI snapshot
Momentum
87
8% active weight
Current posture
7d trendImproving
Δ7d
-
Δ21d
-
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
51
45% active weight
Current posture
7d trendImproving
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 87.2 / Value 40.6 / Sentiment 50.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-14. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$2.30
Analysis reference price unavailable
Analysis 2026-10-14 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.90
Analysis reference price unavailable
Analysis 2026-10-14 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-28
Fundamentals (TTM)
As of 2026-10-28
Market Cap
$179.27M
Beta
0.72
Shares Out
67.14M
P/E (TTM) · Derived
-7.1
P/S (TTM)
812.92
P/FCF (TTM) · Derived
-7.43
Rev YoY
-87.3%
EPS YoY
+25.7%
Gross Margin
+94.2%
Op Margin
-240.3%
Net Debt
-$68.26M
Current Ratio
5.02
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data